Taken together, these results indicate that specific CCN1 knockout or inhibition effectively alleviates myocardial remodeling in CKD mice by suppressing the activation of MAPK signaling, ultimately blocking the progression of cardiorenal syndrome. Here, CCN1 is linked to chronic kidney disease.